The Safety and Efficacy of Rituximab-Based Regimen in Atypical Membranous Nephropathy: A Single Center Retrospective Cohort Study

PURPOSE: There are increasing reports of atypical membranous nephropathy (AMN) cases with similar pathological characteristics to secondary membranous nephropathy (SMN) without definite underlying causes. Although rituximab has become a first-line option in treating idiopathic membranous nephropathy...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Yanan, Zhang, Shuo, Hu, Rongrong, Li, Chao, Chen, Gang, Shi, Xiaoxiao, Liu, Yan, Zheng, Ke, Li, Hang, Wen, Yubing, Li, Xuemei, Li, Xuewang, Xia, Peng, Qin, Yan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10224685/
https://www.ncbi.nlm.nih.gov/pubmed/37251282
http://dx.doi.org/10.2147/IJGM.S410169

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10224685/
https://www.ncbi.nlm.nih.gov/pubmed/37251282
http://dx.doi.org/10.2147/IJGM.S410169

Ejemplares similares